Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 65, Issue 1, 2006, Pages 189-195

  Xu, Zhi Yong ^a,b   Liang, Shi Xiong ^a,c   Zhu, Ji ^a,b   Zhu, Xiao Dong ^c   Zhao, Jian Dong ^a,b   Lu, Hai Jie ^c   Yang, Yun Li ^c   Chen, Long ^c   Wang, An Yu ^c   Fu, Xiao Long ^a,b   Jiang, Guo Liang ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Lyman model; Normal tissue complication probability; Radiation induced liver disease; Three dimensional conformal radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; CELLS; PATIENT MONITORING; PROBABILITY; RADIOTHERAPY; TISSUE;

LYMAN MODEL; NORMAL-TISSUE COMPLICATION PROBABILITY; RADIATION-INDUCED LIVER DISEASE; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY;

DISEASES;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LIVER CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MAXIMUM LIKELIHOOD METHOD; PREDICTION; PRIORITY JOURNAL; PROBABILITY; QUANTUM YIELD; RADIATION DOSE FRACTIONATION; RADIATION INJURY; STATISTICAL MODEL; THREE DIMENSIONAL IMAGING; UNITED STATES;

ADULT; AGED; CHEMOEMBOLIZATION, THERAPEUTIC; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIKELIHOOD FUNCTIONS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY, CONFORMAL;

EID: 33645957655     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.11.034     Document Type: Article

References (25)

1. Zheng Y., Li D.L., Shen Y.Z., et al. Epidemiologic trends and patterns of primary liver cancer in Shanghai. J Surg Concepts Pract 9 (2004) 92-94
2. Li L., Lu F., and Zhang S. Analyses of variation trend and short-term detection of Chinese malignant tumor mortality during twenty years. Zhonghua Zhong Liu Za Zhi 19 (1997) 3-9
3. Ohto M., Yoshikawa M., Saisho H., et al. Nonsurgical treatment of hepatocellular carcinoma in cirrhotic patients. World J Surg 19 (1995) 1942-1946
4. Chuang V.P., and Wallace S. Chemoembolization. Transcatheter management of neoplasms. J Am Med Assoc 245 (1981) 1151-1152
5. Sheu J.C., Huang G.T., Chen D.S., et al. Small hepatocellular carcinoma. Intratumor ethanol treatment using new needle and guidance systems. Radiology 163 (1987) 43-48
6. Ikeda K., Kumada H., Saitoh S., et al. Effects of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 68 (1991) 2150-2154
7. Venook A.P. Treatment of hepatocellular carcinoma. Too many options?. J Clin Oncol 12 (1994) 1323-1334
8. Seong J., Park H.C., Han K.H., et al. Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. Int J Radiat Oncol Biol Phys 47 (2000) 1331-1335
9. Robertson J.M., Lawrence T.S., Dworzanin L.M., et al. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 11 (1993) 1286-1293
10. Park W., Lim D.H., Paik S.W., et al. Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1143-1150
11. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 (1995) 1237-1248
12. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3D dose-volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
13. Cheng J.C., Wu J.-K., Huang C.-M., et al. Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma. Clinical manifestation and dosimetric description. Radiother Oncol 63 (2002) 41-45
14. Liang S.X., Zhu X.D., Xu Z.Y., et al. Radiation-induced liver disease in three-dimensional conformal radiotherapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys (2006) in press.
15. McGinn C.J., Haken R.K.T., Ensminger W.D., et al. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 16 (1998) 2246-2252
16. Ohara K., Okumura T., Tsuji H., et al. Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity. Analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy. Int J Radiat Oncol Biol Phys 38 (1997) 367-372
17. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res 8 Suppl (1985) S13-S19
18. Liang S.X., Zhu X.D., Lu H.J., et al. Hypofractionated three-dimensional conformal radiation therapy for primary liver carcinoma. Cancer 103 (2005) 2181-2188
19. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
20. Kutcher G.J., and Burman C. Calculation of complication probability factors for nonuniform normal-tissue irradiation. The effective volume method. Int J Radiat Oncol Biol Phys 16 (1989) 1623-1630
21. Dawson L.A., and Ten Haken R.K. Partial volume tolerance of the liver to radiation. Sem Radiat Oncol 15 (2005) 279-283
22. Lawrence T.S., Tesser R.J., Ten Haken R.K., et al. An application of dose-volume histogram to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 19 (1990) 1041-1047
23. Cheng J.C., Wu J.K., Huang C.M., et al. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma. Dosimetric analysis and implication. Int J Radiat Oncol Biol Phys 54 (2002) 156-162
24. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
25. Emami A., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122